The global optical genome mapping market is expected to exhibit significant growth over the forecast period owing to the various advantages of optical genome mapping such as its ability to identify structural variations at a much higher resolution as compared to other genome mapping technologies. Optical genome mapping finds wide applications in various areas including diagnostics of genetic disorders, cancer research, personalized medicine, agriculture, and livestock improvement. It helps identify complex genome rearrangements that are difficult to detect using other conventional techniques.

The Global optical genome mapping market is estimated to be valued at US$ 109.9 million in 2024 and is expected to exhibit a CAGR of 21% over the forecast period 2024 to 2031. Increasing investments in genome mapping projects and growing focus on genome analysis are some of the key factors driving the growth of this market.

Key Takeaways
Key players operating in the optical genome mapping market are Bionano Genomics, Nucleome Informatics Private Limited, Praxis Genomics, LLC, SourceBio International Limited (Source BioScience), MedGenome, INRAE (French Plant Genomic Resources Center (CNRGV)), PerkinElmer (PerkinElmer Genomics), Genohub Inc., Hofkens Lab, and Cerba.

The demand for Optical Genome Mapping Market is increasing primarily due to its rising applications in prenatal diagnosis, cancer research, and agricultural research. Optical genome mapping helps identify complex structural variants associated with diseases and developmental disorders, therefore finding increased usage in clinical diagnostics.

Technological advancements are further expanding the potential applications of optical genome mapping. Companies are focused on developing algorithms and software for efficient data analysis from optical genome mapping. Advancements in hardware and consumables are also improving mapping throughput and resolution.

Fastest Growing Region in Global Optical Genome Mapping Market
Asia Pacific region is poised to be the fastest growing region in the global optical genome mapping market during the forecast period. This is attributed to rising healthcare expenditures, increasing awareness about genetic disorders and personalized medicine, large cancer disease burden as well as growing collaborations between regional and international market players. China and India with their huge population base and unmet medical needs represent lucrative growth opportunities. Favourable regulatory environment supporting clinical adoption of genomic technologies further boosts the adoption of optical genome mapping systems in the region. Expanding network of genome sequencing centers and initiatives such as 100,000 Genomes Project in China and Genomic England Project are positively impacting the Asia Pacific optical genome mapping market.

Get more insights on Optical Genome Mapping Market